🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Rare Diseases ── Platforms ── 2026-11-19

1 Platforms papers. Lead: Identification of Core Ferroptosis Regulatory Genes in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Single-Cell Transcriptomics and Multi-Cohort Machine Learning.

Journals covered and how papers are chosen: see the index

Rare-disease diagnosis and drug discovery platforms and AI

← Back to this issue